Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.08 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 08/6/15 All times are local (Market data is delayed by at least 15 minutes).

polynovo ltd (CALZF) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/13/14 - $0.08
52 Week Low
06/10/15 - $0.04
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for POLYNOVO LTD (CALZF)

Related News

No related news articles were found.

polynovo ltd (CALZF) Related Businessweek News

No Related Businessweek News Found

polynovo ltd (CALZF) Details

Polynovo Limited, a medical device company, designs, develops, and manufactures solutions for standalone and combination devices. The company develops NovoSorb, a biodegradable polymer technology for use in manufacturing medical devices designed to support tissue repair and then degrade in a defined fashion in-situ to harmless by-products. Its products include BTM (biodegradable temporising matrix), a wound dressing intended for treatment of full-thickness wounds and burns, including 3rd degree burns and surgical wounds; and NovoPore for use as a dressing in negative pressure wound therapy to remove excess fluid from chronic wounds, such as pressure sores. The company was formerly known as Calzada Limited and changed its name to Polynovo Limited in November 2014. Polynovo Limited is based in Port Melbourne, Australia.

polynovo ltd (CALZF) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: A$91.8K
Chief Financial Officer and Company Secretary
Total Annual Compensation: A$196.6K
Chief Executive Officer of PolyNovo Biomateri...
Total Annual Compensation: A$140.5K
Chief Executive Officer of Metabolic Pharmace...
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

polynovo ltd (CALZF) Key Developments

Polynovo Limited Announces Executive Changes

Polynovo Limited announced that Mr. Paul Brennan commenced in his role as Chief Executive Officer on Feb. 13, 2015. Paul has been in the Health Sciences area for over 20 years in roles with major market leading global healthcare companies. He possesses extensive commercial experience encompassing product development, new product introduction, market analysis, quality systems process development, reimbursement strategies, regulatory pathways and competitor analysis. The Board also announced that Ms. Ivy Cheng has been appointed to the newly created position of Regulatory Affairs & Clinical Compliance Manager. Ivy comes with strong credentials to this important position as PolyNovo seeks to undertake regulatory trials to register products, especially in the area of wound and burns. She will commence in mid-March 2015. Philip Powell and David McQuillan will revert immediately to Independent Non-Executive Directors.

Calzada Ltd will Change its Name to Polynovo Ltd

Effective December 02, 2014, Calzada Ltd will change its name to Polynovo Ltd.

Calzada Limited Announces Appointment of Paul Brennan as Chief Executive Officer

Calzada Ltd. announced the appointment of Mr. Paul Brennan as Chief Executive Officer. Since 2008 Paul has been the Marketing Director Australia and New Zealand and Sales Director New Zealand of Smith and Nephew. Smith and Nephew are a global leading wound care, orthopedic implant, endoscopy and biologic manufacturer.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CALZF:US $0.08 USD 0.00

CALZF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CALZF.
View Industry Companies

Industry Analysis


Industry Average

Valuation CALZF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1,904.0x
Price/Book 5.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1,753.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact POLYNOVO LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at